The Honest
Valuation each multiple against its own 5-year range
Vs. peers Household & Personal Products
| Company | Market cap | P/E (TTM)i | P/Bi | Div yieldi |
|---|---|---|---|---|
| The Honest (HNST) | 543.93M | -46.09 | 3.26 | 0.00% |
| Procter & Gamble (PG) | 351.26B | 22.84 | 6.59 | 2.82% |
| Unilever (UL) | 134.08B | 13.11 | 7.39 | 3.58% |
| Colgate-Palmolive (CL) | 70.37B | 34.75 | 298.21 | 2.37% |
| Estee Lauder (EL) | 35.53B | 196.10 | 9.33 | 1.43% |
| Kenvue (KVUE) | 34.00B | 20.82 | 3.22 | 4.69% |
Other StockVane-tracked companies in the same industry.
Morningstar
Trading 1.8% below Morningstar's fair value estimate.
Fair value
The Honest Co Inc is assigned a 3-star quantitative star rating, illustrating our stance that this share class is a balanced choice, but prudent investors should consider looking elsewhere. The stock currently trades at a 4% discount to our quantitative fair value estimate of $5.16 per share; however, caution is warranted due to this estimate's high uncertainty rating.
The firm's liquidity strengthens our quantitative valuation. Adequate liquidity allows a company to meet short-term obligations, enhancing financial stability and reducing distress risk. Reflecting the firm's liquidity is its median trading volume over the past 60 days, which falls in the top 30% globally. Trading volumes are high on shares, which may indicate increased institutional interest in stock ownership. We believe this is a sign that shares could be cheap.
On a different note, the company's lack of profitability is potentially concerning. Companies with low profitability are often less resilient in recessions and are likely to generate weaker future cash flows for shareholders. The firm's earnings yield of -0.05%, for example, falls in the bottom 30% compared with peers globally. The earnings generated by the company relative to its share price is concerning, which, despite our favorable price/fair value ratio, is a negative attribute.
Economic moat
With its quantitative economic moat rating of none, we do not expect this company to materially outearn its cost of capital in the long run. Additionally, the firm's moderate financial health score suggests it is acceptably positioned against adverse economic circumstances.
By Quantitative Equity Report
Quote time 2026-10-09 19:30:06 · For reference only, not investment advice and not tailored to your situation.
The Honest discussion 0 comments